Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Glenmark Pharmaceuticals (GLENMARK.NSE) Q1 2025 Earnings
GLENMARK.NSE
15
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-43.97
-24.38
-4.78
14.82
Details
Expected EPS
14.18652827856
Actual EPS
12.41952297696
Surprise EPS
-1.77
Surprise Percent
+12.46%
Description
Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 12.41952297696 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login